Abstract:Hyperhomocysteinemia is believed to be responsible for the development of vascular disease via several mechanisms, including the impairment of endothelial-cell functionality. In-vitro studies have demonstrated that homocysteine decreases the production or bioavailability of vasodilator autacoids, such as prostacyclin and NO. Here, we show that the treatment of human endothelial cells with noncytotoxic homocysteine concentrations leads to a dose-dependent decrease in both the secretion of the vasoconstrictor agent endothelin-1 (ET-1) and the level of its mRNA. Homocysteine had an inhibitory effect at pathophysiological (0.1 and 0.5 mmol.L(-1)) and pharmacological noncytotoxic (1.0 and 2.0 mmol.L(-1)) concentrations. Mean percentage variation from control for ET-1 production was -36. 2 +/- 18.9% for 0.5 mmol.L(-1) homocysteine and -41.5 +/- 26.8% for 1.0 mmol.L(-1) homocysteine, after incubation for 8 h. Mean percentage variation from control for steady-state mRNA was -17.3 +/- 7.1% for 0.5 mmol.L(-1) homocysteine and -46.0 +/- 10.1 for 1.0 mmol.L(-1) homocysteine, after an incubation time of 2 h. ET-1 production was also reduced by incubation with various other thiol compounds containing free thiol groups, but not by incubation with thiol compounds with no free thiol group. Co-incubation of cells with homocysteine and the sulfhydryl inhibitor N-ethylmaleimide prevented the effect of homocysteine on ET-1 production, confirming a sulfhydryl-dependent mechanism. Based on the reciprocal feedback mechanism controlling the synthesis of vasoactive mediators, these preliminary data suggest a mechanism by which homocysteine may selectively impair endothelium-dependent vasodilation by primary inhibition of ET-1 production.

Synthesis and Characterization of Eu-doped ZnO Nanomaterials Prepared by Microwave-induced Combustion

Preparation and Photoluminescence of ZnO with Nanostructure by Hollow-Cathode Discharge

Characterization of Ce3+ and Eu3+ doped and co-doped ZnO nanoparticles for luminescence applications

Preparation and Characterization of ZrO2:Eu3+ Phosphors

A valence states approach for luminescence enhancement by low dopant concentration in Eu-doped ZnO nanoparticles

Homocysteine decreases endothelin-1 production by cultured human endothelial cells.

Structures and Optical Properties of Eu^3＋ Ion Doped Zinc-alumino-silicate Glass-ceramics

Efficient Energy Transfer in Monodisperse Eu-Doped ZnO Nanocrystals Synthesized from Metal Acetylacetonates in High-Boiling Solvents

Synthesis and Photoluminescence of Eu3+ and O2- Co-Doped ZnS Nanoparticles with Yellow Emission Synthesized by a Solid-State Reaction

ZnO:Eu thin-films: Sol–gel derivation and strong photoluminescence from 5D0→7F0 transition of Eu3+ ions

Synthesis and photoluminescence properties of ZnO powder by solution combustion method

Low temperature chemical reaction synthesis of single-crystalline Eu(OH)<sub>3</sub> nanorods and their thermal conversion to Eu<sub>2</sub>O<sub>3</sub> nanorods

Preparation Of Europium (Iii) Doped Nanocrystalline Zinc Oxide In Ionic Liquid Via An Ultrasonic Irradiation

Study on Microstructure and Photoluminescence Properties of Eu,Mg Co-Doped ZnO Thin Films

Influence of Mg doping on the microstructure and PL emission of wurtzite ZnO synthesized by microwave processing

Synthesis, characterization, and photoluminescence investigations of Al/Co-doped ZnO nanopowder

Luminescence Enhancement Due to Energy Transfer in ZnO Nanoparticles and Eu3+ Ions Co-Doped Silica

Preparation and Luminescence of ZrO_2 Nanopowders Via Solvothermal Method

Effect of Synthesis Temperature on Structural, Optical, and Magnetic Properties of ZnO Nanoparticles Synthesized by Combustion Method

Photoluminescence Properties of Eu3+-Doped Zns Nanocrystals Prepared in A Water/Methanol Solution

Controllable synthesis of Zn2GeO4:Eu nanocrystals with multi-color emission for white light-emitting diodes